Syncom Formulations

Syncom Formulations

17.28
-0.09
(-0.52%)
ann
There are new updates from the company15 hours ago
Viewcross
right
Market Cap
1,624.32 Cr
EPS
0.57
PE Ratio
28.48
Dividend Yield
0.00 %
Industry
Healthcare
52 Week High
23.87
52 Week Low
14.10
PB Ratio
4.77
Debt to Equity
0.12
Add Ratio
hide

Investment Returns

In Long Term
In Short Term
1 Year
0.00%
2 Years
0.00%
3 Years
0.00%
4 Years
0.00%
5 Years
0.00%

Company News

View All News
Caret
negative
Syncom Formulations (India) Limited announced the resignation of two key executives effective August 8, 2025. Shri Ankit Kedarmal Bankda resigned from his position as Chief Financial Officer, while Smt. Rinki Ankit Banka stepped down from her roles as Director and Whole-time Director. The company filed the disclosure on August 18, 2025, explaining that the delay in submitting resignation letters was due to internal processing and final settlement formalities with the departing executives. The resignations affect the company's senior management structure and board composition.
positive
Syncom Formulations (India) delivered robust Q1 performance with revenue rising to 1.17 billion rupees from 872.6 million rupees year-over-year. Net profit more than doubled to 158 million rupees compared to 76.3 million rupees in the same period last year. EBITDA increased to 158 million rupees from 104.5 million rupees, while EBITDA margin improved to 13.52% from 11.98% year-over-year, indicating enhanced operational efficiency alongside revenue growth.
neutral
Syncom Formulations Board Approves Changes to Articles and Memorandum of AssociationAug 08, 2025
Syncom Formulations (India) Limited's Board of Directors approved alterations to the company's Articles of Association and Memorandum of Association at a meeting held on August 8, 2025. The changes include inserting new articles related to power purchase agreements, projects, sweat equity shares, and ESOP provisions. The Board also approved substituting the existing dividend waiver article and adding new business clauses for nutraceuticals, dietary supplements, wellness products, and real estate development activities. All proposed changes are subject to shareholder approval at the upcoming 37th Annual General Meeting scheduled for September 29, 2025.
View more
Competitors
LTP
Market Cap (₹ Cr.)
P/E Ratio
Revenue (₹ Cr.)
YoY Revenue Growth %
Net Profit (₹ Cr.)
YoY Profit Growth %
RSI
1,627.90
#1 3,90,587.74
34.12
#1 54,729.00
9.71
#1 10,980
-19.84
57.06
6,046.00
1,60,502.30
69.65
9,712.00
18.67
2,191
26.74
46.95
3,647.10
1,23,434.44
61.22
11,539.40
6.99
1,911
19.91
59.63
1,520.40
1,22,803.90
22.89
28,409.50
7.12
5,291
9.88
45.54
1,301.00
1,08,577.70
#1 19.22
33,741.20
16.73
5,725
1.26
55.14
2,546.50
1,05,101.38
55.95
12,744.20
#1 20.90
2,007
-18.14
53.77
1,039.95
1,04,643.30
22.56
23,511.00
18.55
4,615
2.60
60.18
2,001.90
91,425.87
24.76
22,909.50
13.74
3,306
#1 51.64
54.28
5,543.50
66,280.86
29.19
13,458.30
3.70
2,216
21.39
64.54
30,155.00
64,077.27
44.26
6,684.70
9.64
1,414
11.55
33.05

Automatic Screeners on ScanX

Forecast
Actual
Growth Rate
Revenue Growth
-
Net Income Growth
-
Cash Flow Change
493.29 %
ROE
-
ROCE
-
EBITDA Margin (Avg.)
-

Quarterly Financial Results

Quarterly Financials
Jun 2021
Sept 2021
Dec 2021
Mar 2022
Jun 2022
Sept 2022
Dec 2022
Mar 2023
Jun 2023
Sept 2023
Dec 2023
Mar 2024
Jun 2024
Sept 2024
Dec 2024
Mar 2025
Jun 2025
Revenue
53
56
60
64
54
57
59
68
62
68
70
78
89
107
132
156
123
Expenses
44
47
52
56
48
50
52
55
53
57
58
65
77
90
113
131
101
EBITDA
8
8
7
8
7
7
8
13
8
10
12
13
12
16
19
25
22
Operating Profit %
14 %
11 %
9 %
3 %
7 %
8 %
10 %
10 %
11 %
10 %
11 %
13 %
12 %
12 %
12 %
12 %
14 %
Depreciation
1
1
1
1
1
1
1
1
1
1
2
1
1
1
1
1
1
Interest
0
0
0
1
1
1
1
1
1
1
1
1
0
0
0
0
0
Profit Before Tax
7
7
6
6
5
5
6
10
6
8
9
10
10
15
17
23
20
Tax
2
2
2
1
1
2
2
2
2
2
2
3
3
4
4
6
5
Net Profit
5
6
4
5
4
4
4
9
4
7
7
7
8
11
13
18
16
EPS in ₹
0.07
0.06
0.07
0.05
0.03
0.06
0.06
0.10
0.07
0.08
0.09
0.10
0.11
0.16
0.14
0.16
0.21

Balance Sheet

Balance Sheet
2015
2016
2017
2022
2023
2024
2025
Total Assets
138
175
180
308
378
405
413
Fixed Assets
46
46
55
94
91
120
125
Current Assets
79
86
83
140
182
275
270
Capital Work in Progress
0
5
0
6
26
0
0
Investments
0
0
0
43
64
66
93
Other Assets
92
125
125
165
197
219
196
Total Liabilities
138
175
180
308
378
405
413
Current Liabilities
32
60
55
78
113
107
59
Non Current Liabilities
6
6
8
8
9
10
12
Total Equity
100
109
117
222
256
288
342
Reserve & Surplus
22
31
39
131
162
194
248
Share Capital
78
78
78
86
94
94
94

Cash Flow

Cash Flow
2015
2016
2017
2022
2023
2024
2025
Net Cash Flow
2
-1
1
-3
1
63
-63
Investing Activities
1
-23
-18
-27
-45
83
-18
Operating Activities
0
24
14
16
11
-6
23
Financing Activities
1
-2
5
8
35
-15
-68

Share Holding

% Holding
Mar 2021
Jun 2021
Sept 2021
Dec 2021
Mar 2022
Jun 2022
Sept 2022
Nov 2022
Dec 2022
Mar 2023
Jun 2023
Sept 2023
Dec 2023
Mar 2024
Jun 2024
Sept 2024
Dec 2024
Mar 2025
Jun 2025
Promoter
41.18 %
41.18 %
44.01 %
44.01 %
46.12 %
50.57 %
50.57 %
50.57 %
50.57 %
50.57 %
50.57 %
50.57 %
50.57 %
50.57 %
50.57 %
50.57 %
50.57 %
50.57 %
50.57 %
FIIs
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.08 %
0.09 %
0.10 %
0.13 %
0.11 %
0.41 %
DIIs
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
Government
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
Public / Retail
54.31 %
54.11 %
51.35 %
51.08 %
49.68 %
44.86 %
44.91 %
45.03 %
45.02 %
44.85 %
45.00 %
44.76 %
44.82 %
44.85 %
45.08 %
45.14 %
45.06 %
45.20 %
44.83 %
Others
4.51 %
4.71 %
4.64 %
4.90 %
4.19 %
4.57 %
4.52 %
4.40 %
4.41 %
4.59 %
4.43 %
4.67 %
4.61 %
4.50 %
4.27 %
4.18 %
4.24 %
4.12 %
4.19 %
No of Share Holders
72,450
93,207
1,20,800
1,88,981
2,32,617
2,35,517
2,32,749
2,31,495
2,32,069
2,27,478
2,24,925
2,24,252
2,89,982
3,25,761
3,76,530
4,69,242
4,89,520
4,84,529
4,71,066

Dividend History

Dividends per share (FY)
Dividend yield (FY) %
Dividends per share (FY)
Dividend yield (FY) %
Annual Cash Flows 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
Dividend Per Share (₹) 0.00 0.00 0.00 0.00 0.00 0.00 0.03 0.00 0.00 0.00
Dividend Yield (%) 0.00 0.00 0.00 0.00 0.00 0.00 0.5 0.00 0.00 0.00

Corporate Action

Record Date Corporate Action Information Announcement Day LTP at Annoucement LTP at Record Day
29 Sept 2025 ANNUAL GENERAL MEETING Annual General Meeting
NA
29 Sept 2025 18.27 17.37
13 Sept 2022 DIVIDEND Dividend
₹ 0.03 /share
09 Sept 2022 9.18 9.18
26 Sept 2023 ANNUAL GENERAL MEETING Annual General Meeting
NA
26 Sept 2023 9.14 8.50
30 Sept 2024 ANNUAL GENERAL MEETING Annual General Meeting
NA
30 Sept 2024 23.19 21.98
11 Nov 2024 QUARTERLY RESULT ANNOUNCEMENT Quarterly Result Announcement
NA
11 Nov 2024 20.83 20.52
10 Feb 2025 QUARTERLY RESULT ANNOUNCEMENT Quarterly Result Announcement
NA
10 Feb 2025 18.44 18.44
19 May 2025 QUARTERLY RESULT ANNOUNCEMENT Quarterly Result Announcement
NA
19 May 2025 16.44 17.51
08 Aug 2025 QUARTERLY RESULT ANNOUNCEMENT Quarterly Result Announcement
NA
08 Aug 2025 18.01 17.88

Announcements

Closure of Trading Window15 hours ago
Announcement under Regulation 30 (LODR)-Newspaper PublicationSep 06, 2025
Business Responsibility and Sustainability Reporting (BRSR)Sep 04, 2025
Reg. 34 (1) Annual Report.Sep 04, 2025
Notice Of Annual General Meeting Of Syncom Formulations (India) Limited.Sep 04, 2025
Announcement under Regulation 30 (LODR)-Newspaper PublicationSep 02, 2025
Intimation Regarding 100 Days Campaign - Saksham Niveshak From 28Th July 2025 To 6Th November 2025 Update Your KYC Details And Claim Your Unpaid/ Unclaimed Dividends.Aug 27, 2025
Intimation Regarding 100 Days Campaign - Saksham Niveshak From 28Th July 2025 To 6Th November 2025 Update Your KYC Details And Claim Your Unpaid/ Unclaimed Dividends.Aug 27, 2025
Announcement under Regulation 30 (LODR)-Change in ManagementAug 18, 2025
Announcement under Regulation 30 (LODR)-Newspaper PublicationAug 09, 2025
Pursuant To Reg 44 SEBI LODR Remote E Voting Facility For 37Th AGMAug 08, 2025
BOOK CLOSURE FOR 37TH AGM TO BE HELD ON 29TH SEPTEMBER 2025Aug 08, 2025
Announcement under Regulation 30 (LODR)-Amendments to Memorandum & Articles of AssociationAug 08, 2025
Announcement under Regulation 30 (LODR)-Change in ManagementAug 08, 2025
Announcement under Regulation 30 (LODR)-Change in ManagementAug 08, 2025
Board Meeting Outcome for Outcome Of The 2/2025-26 Meeting Of The Board Of Directors Of The CompanyAug 08, 2025
Results- Financial Results 30.06.2025Aug 08, 2025
Board Meeting Intimation for Corporate Announcement U/R 29(1)(A) Of SEBI (LODR) Regulations 2015 Read With SEBI (PIT) Regulations 2015 Regarding Intimation Of Holding The 2/2025-26 Board MeetingAug 02, 2025
Dispatch Of KYC Letters To Shareholders Requiring Copy Of Bank Accounts Details Copy Of PAN Card KYC Details And Nomination As Per SEBI Circular.Jul 17, 2025
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018Jul 08, 2025
Closure of Trading WindowJun 25, 2025
Announcement Under Regulations 30 (LODR)Jun 12, 2025
Compliances-Reg.24(A)-Annual Secretarial ComplianceMay 21, 2025
Announcement under Regulation 30 (LODR)-Newspaper PublicationMay 20, 2025
Results For The Quarter And Year Ended 31.03.2025May 19, 2025
Board Meeting Outcome for Regulation 33(3)(D) Of SEBI (LODR) Regulations 2015-Submission Of Standalone & Consolidated Audited Financial Results Along With Audit Report Statement Of Assets And Liabilities And Cash Flow For The Year Ended On 31St March 2025May 19, 2025
Board Meeting Intimation for Corporate Announcement U/R 29(1)(A) Of SEBI (LODR) Regulations 2015 Read With SEBI (PIT) Regulations 2015 Regarding Intimation Of Holding The 1/2025-26 Board Meeting For The Quarter And Year Ended On 31St March 2025May 13, 2025
Format of the Initial Disclosure to be made by an entity identified as a Large Corporate : Annexure AMay 13, 2025
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018Apr 17, 2025
Announcement Under Regulation 30Apr 05, 2025
Closure of Trading WindowMar 25, 2025
Disclosure under Regulation 30A of LODRFeb 13, 2025
Announcement under Regulation 30 (LODR)-Newspaper PublicationFeb 11, 2025
Integrated Filing (Financial)Feb 10, 2025
Regulation 33(3) Of SEBI (LODR) Regulations 2015 - Submission Of Standalone & Consolidated Unaudited Financial Results Along With Limited Review Report For The Quarter And Nine Months Ended On 31St DeFeb 10, 2025
Compliances-Reg. 50 (1) - Prior intimation about Board meeting under Regulation 50(1)Feb 03, 2025
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018Jan 21, 2025
Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate CertificateNov 26, 2024
Announcement under Regulation 30 (LODR)-Newspaper PublicationNov 12, 2024
Regulation 33(3) Of SEBI (LODR) Regulations, 2015 - Submission Of Standalone & Consolidated Unaudited Financial Results Along With Limited Review Report, Statement Of Assets And Liabilities And Cash Flow For The Quarter And Half Year Ended On 30Th September, 2024.Nov 11, 2024
Board Meeting Intimation for Corporate Announcement U/R 29(1)(A) Of SEBI (LODR) Regulations, 2015 Regarding Intimation Of Holding Board Meeting For Consideration And Approval Of The Standalone And Consolidated Unaudited Financial Results,Nov 04, 2024
Submission Of The Minutes Of The 36Thannual General Meeting Held On 30Th September, 2024Oct 17, 2024
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018Oct 11, 2024
Announcement under Regulation 30 (LODR)-Change in DirectorateOct 03, 2024
Shareholder Meeting / Postal Ballot-Outcome of AGMOct 03, 2024
Shareholder Meeting / Postal Ballot-Scrutinizer''s ReportOct 03, 2024
Declaration Of Results Of Remote E-Voting And E-Voting At 36Th Annual General Meeting, Incompliance With Regulation 44(3) Of SEBI (LODR) Regulation, 2015 In Relation To The 36Thannual General Meeting Of The Company Held On 30Th September, 2024.Oct 03, 2024
Submission Of Proceedings Of The 36Thannual General Meeting Of The Company Held On Monday, 30Th September, 2024 Pursuant To Regulation 30(2) Read With Part A Of Schedule III Of The SEBI (LODR) Regulations, 2015.Sep 30, 2024
Closure of Trading WindowSep 25, 2024
Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate CertificateSep 13, 2024

Technical Indicators

RSI(14)
Neutral
44.48
ATR(14)
Volatile
0.53
STOCH(9,6)
Neutral
46.23
STOCH RSI(14)
Neutral
40.50
MACD(12,26)
Bullish
0.05
ADX(14)
Weak Trend
18.24
UO(9)
Bearish
32.83
ROC(12)
Uptrend But Slowing Down
0.93
WillR(14)
Neutral
-78.24

Mutual Fund Holdings

Funding HouseCurrent Holding %1M Change1M Change %3M Change %Last 6M Trend
Bandhan BSE Healthcare Index Fund Direct-Growth
0.06%
-24
0.00%
-0.01%